Examining examples separately, CCND3 mutation occurred in 2 cases: one patient with melanoma (concurrent KIT and BRAF non-V600 mutations) and a second with NSCLC (concurrent TP53 mutation), and within two months of follow-up both of these patients had died. This evidence concerns the gene BRAF and melanoma.